ERBB2 and breast carcinoma: Comparison of the expression of HMGB1 mRNA in patients with breast cancer with luminal A, luminal B, HER2, and basal-like subtypes using microarray and RNA-seq public datasets revealed significantly higher HMGB1 mRNA levels in the basal-like subtype than those in other subtypes (Fig. 1B).